PCSK9 wrangle opens can of worms for antibody makers
Regeneron and Sanofi's PCSK9 court win could reverberate across the whole monoclonal antibody space.
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.